Detection of moderate hepatic steatosis on contrast-enhanced dual-source dual-energy CT: Role and accuracy of virtual non-contrast CT

被引:2
作者
Catania, Roberta [1 ]
Jia, Leo [1 ]
Haghshomar, Maryam [1 ]
Miller, Frank H. [1 ]
Borhani, Amir A. [1 ]
机构
[1] Northwestern Univ, Dept Radiol, Feinberg Sch Med, 676 N St Clair St, Arkes Family Pavil, Suite 800, Chicago, IL 60611 USA
关键词
Dual-energy CT; Spectral CT; Virtual non-contrast; Virtual unenhanced; Fatty liver; Steatosis; FATTY LIVER-DISEASE; TOMOGRAPHY PHYSICAL PRINCIPLES; COMPUTED-TOMOGRAPHY; QUANTIFICATION; INFILTRATION; ASSOCIATION; DIAGNOSIS; USAGE; MRI;
D O I
10.1016/j.ejrad.2024.111328
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To investigate diagnostic accuracy of virtual non contrast (VNC) images, based on dual-source dualenergy CT (dsDECT), for detection of at least moderate steatosis and to define a threshold value to make this diagnosis on VNC. Methods: This single-institution retrospective study included patients who had multi-phasic protocol dsDECT. Regions of interests were placed in different segments of the liver and spleen on true non-contrast (TNC), VNC, and portal-venous phase (PVP) images. At least moderate steatosis was defined as liver attenuation (LHU) < 40 HU on TNC. Diagnostic performance of VNC to detect steatosis was determined and the new threshold was tested in a validation cohort. Results: 236 patients were included in training cohort. Mean liver attenuation values were 51.3 +/- 10.8 HU and 58.1 +/- 11.5 HU for TNC and VNC (p < 0.001), with a mean difference (VNC - TNC) of 6.8 +/- 6.9 HU. Correlation between TNC and VNC was strong (r = 0.81, p < 0.001). The AUCs of LHU on VNC for detection of hepatic steatosis were 0.92 (95 % Cl: 0.86-0.98), 0.92 (95 % Cl: 0.87-0.97), 0.92 (95 % Cl: 0.86-0.99), 0.91 (95 % Cl: 0.84-0.97), and 0.87 (95 % Cl: 0.80-0.95) for entire liver, left lateral, left medial, right anterior, and right posterior segments, respectively. VNC had sensitivity/specificity of 100 % /42 % when using a threshold of 40 HU; they were 69 % and 95 %, respectively, when using optimized threshold of 46 HU. This threshold showed similar performance in validation cohort (n = 80). Conclusions: Hepatic attenuation on VNC has promising performance for detection of at least moderate steatosis. Proposed threshold of 46 HU provides high specificity and moderate sensitivity to detect steatosis.
引用
收藏
页数:7
相关论文
共 44 条
[1]  
Benedict M, 2017, WORLD J HEPATOL, V9, P715, DOI 10.4254/wjh.v9.i16.715
[2]   COMPARISON OF CONTRAST-MEDIA INJECTION RATES AND VOLUMES FOR HEPATIC DYNAMIC INCREMENTED COMPUTED-TOMOGRAPHY [J].
BERLAND, LL ;
LEE, JY .
INVESTIGATIVE RADIOLOGY, 1988, 23 (12) :918-922
[3]   Comparison of true unenhanced and virtual unenhanced (VUE) attenuation values in abdominopelvic single-source rapid kilovoltage-switching spectral CT [J].
Borhani, Amir A. ;
Kulzer, Matthew ;
Iranpour, Negaur ;
Ghodadra, Anish ;
Sparrow, Mark ;
Furlan, Alessandro ;
Tublin, Mitchell E. .
ABDOMINAL RADIOLOGY, 2017, 42 (03) :710-717
[4]   Medical liver biopsy: background, indications, procedure and histopathology [J].
Boyd, Alexander ;
Cain, Owen ;
Chauhan, Abhishek ;
Webb, Gwilym James .
FRONTLINE GASTROENTEROLOGY, 2020, 11 (01) :40-47
[5]   Dual-layer dual-energy CT for characterization of adrenal nodules: can virtual unenhanced images replace true unenhanced acquisitions? [J].
Cao, Jinjin ;
Lennartz, Simon ;
Parakh, Anushri ;
Joseph, Evita ;
Blake, Michael ;
Sahani, Dushyant ;
Kambadakone, Avinash .
ABDOMINAL RADIOLOGY, 2021, 46 (09) :4345-4352
[6]  
Catania R., 2023, Effect of tube voltage on hepatic attenuation in normal and steatotic liver
[7]  
in vitro and in vivo study
[8]   The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Charlton, Michael ;
Cusi, Kenneth ;
Rinella, Mary ;
Harrison, Stephen A. ;
Brunt, Elizabeth M. ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :328-357
[9]   Nonalcoholic fatty liver disease [J].
Clark, JM ;
Brancati, FL ;
Diehl, AM .
GASTROENTEROLOGY, 2002, 122 (06) :1649-1657
[10]   BOLUS GEOMETRY AND DYNAMICS AFTER INTRAVENOUS CONTRAST-MEDIUM INJECTION [J].
CLAUSSEN, CD ;
BANZER, D ;
PFRETZSCHNER, C ;
KALENDER, WA ;
SCHORNER, W .
RADIOLOGY, 1984, 153 (02) :365-368